Neurodegenerative conditions such as Parkinson’s disease and Alzheimer’s involve progressive neuronal loss due to disease-induced damage. An enzyme known as dual leucine-zipper kinase (DLK) plays a key role in this process, telling neurons that are damaged or unhealthy when they should cut their losses and self-destruct. Hence, sparing neurons from DLK is an attractive therapeutic strategy that could slow disease progression.
A new study shows that a switch of just two weeks from a traditional African diet to a Western diet causes inflammation, reduces the immune response to pathogens, and activates processes associated with lifestyle diseases. Conversely, an African diet rich in vegetables, fiber, and fermented foods has positive effects.
Every year, more than 795,000 American adults suffer a stroke, and one in four adults worldwide will suffer a stroke in their lifetime. Early action can reduce rates of death and disability.
Are people with attention deficit disorder with or without hyperactivity (ADHD) more likely to listen to background music while performing daily tasks?
The US drug regulator has missed a deadline for granting full approval to Novavax’s COVID-19 vaccine, the company said Wednesday, amid major shakeups at health agencies under President Donald Trump.
Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis when applied topically in an emollient cream.
A new study has found that young vapers in the United States who begin using e-cigarettes after graduating from secondary/high school are likely to progress rapidly to frequent use.
Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding developmental processes. While not exact replicas of human organs, they offer significant insights.
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
A study led by pediatric ophthalmology researcher Carolyn Drews-Botsch of George Mason University can help parents and health care providers decide whether or not to continue patching their children who were treated for unilateral congenital cataract (UCC) after the child’s vision can be reliably tested.